AGM launches its own range of graphene paints alongside another high-performance non-metal additive.
Following outstanding results through extensive inhouse research and testing, the company has launched a range of industrial anti-corrosion paint incorporating its own Genable graphene additives. The two epoxy-based prototype primer systems represent an easy way for those considering the adoption of graphene to quickly test and evaluate its potential benefits.
The Genable Epoxy primer is a C3-rated hybrid product combining graphene with a zinc phosphate additive to enable the end-user to benefit from the synergies offered by both systems in standard applications, such as urban and industrial environments. The Genable CX primer is a high-performance hybrid system, but this formulation is based on graphene and aluminium chemistries to offer anti-corrosion protection for harsh environments, such as offshore and marine applications.
Alongside the graphene-enhanced paints, AGM chemists have also introduced a range of non-metal, active anti-corrosion graphene additives to extend its Genable 3000 dispersion series. Using a combination of graphene with traditional, sacrificial additives, the newly-formulated metal-free and VOC-free hybrid range maximises synergies across complimentary systems to offer the paints and coatings industry an unrivalled level of surface protection against corrosion.
Genable 3100 and Genable 3105 are optimised, formulation-ready dispersions that are easy to formulate, safe to incorporate and stabilised in a standard epoxy resin. The Genable 3120 offers a more sustainable option in an eco-friendly, bio-based epoxy resin to boost anti-corrosion performance whilst contributing to environmental goals. The new graphene additives are based on the Company’s well-established Genable technology, which is already proven to deliver significant performance uplifts such as chemical resistance, barrier and anticorrosion properties.
Adrian Potts, Chief Executive Officer or AGM said: “We are pleased to be able to launch these new Genable products, which we anticipate will help further accelerate the adoption of graphene nanoplatelet technology in the industry. Our technology development programmes have focused on extensive testing and evaluation for a range of applications, and this experience is valuable to guide customers in the use of our products.”
